Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer

被引:72
作者
Palmer, Catherine S. [1 ,2 ]
Anderson, Alexander J. [1 ,2 ]
Stojanovski, Diana [1 ,2 ]
机构
[1] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia
关键词
Alzheimer' s disease; cancer; Huntington' mitochondria; neurodegeneration; Parkinson' protein import; TIM; TOM;
D O I
10.1002/1873-3468.14022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The majority of proteins localised to mitochondria are encoded by the nuclear genome, with approximately 1500 proteins imported into mammalian mitochondria. Dysfunction in this fundamental cellular process is linked to a variety of pathologies including neuropathies, cardiovascular disorders, myopathies, neurodegenerative diseases and cancer, demonstrating the importance of mitochondrial protein import machinery for cellular function. Correct import of proteins into mitochondria requires the co-ordinated activity of multimeric protein translocation and sorting machineries located in both the outer and inner mitochondrial membranes, directing the imported proteins to the destined mitochondrial compartment. This dynamic process maintains cellular homeostasis, and its dysregulation significantly affects cellular signalling pathways and metabolism. This review summarises current knowledge of the mammalian mitochondrial import machinery and the pathological consequences of mutation of its components. In addition, we will discuss the role of mitochondrial import in cancer, and our current understanding of the role of mitochondrial import in neurodegenerative diseases including Alzheimer's disease, Huntington's disease and Parkinson's disease.
引用
收藏
页码:1107 / 1131
页数:25
相关论文
共 237 条
[11]  
2-M
[12]   Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion [J].
Armstrong, LC ;
Komiya, T ;
Bergman, BE ;
Mihara, K ;
Bornstein, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6510-6518
[13]   Treatment of Mitochondrial Disorders [J].
Avula, Sreenivas ;
Parikh, Sumit ;
Demarest, Scott ;
Kurz, Jonathan ;
Gropman, Andrea .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (06)
[14]   Tom70 enhances mitochondrial preprotein import efficiency by binding to internal targeting sequences [J].
Backes, Sandra ;
Hess, Steffen ;
Boos, Felix ;
Woellhaf, Michael W. ;
Goedel, Sabrina ;
Jung, Martin ;
Muehlhaus, Timo ;
Herrmann, Johannes M. .
JOURNAL OF CELL BIOLOGY, 2018, 217 (04) :1369-1382
[15]   MIA40 is an oxidoreductase that catalyzes oxidative protein folding in mitochondria [J].
Banci, Lucia ;
Bertini, Ivano ;
Cefaro, Chiara ;
Ciofi-Baffoni, Simone ;
Gallo, Angelo ;
Martinelli, Manuele ;
Sideris, Dionisia P. ;
Katrakili, Nitsa ;
Tokatlidis, Kostas .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (02) :198-206
[16]   Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature [J].
Bao, Xuanwen ;
Shi, Run ;
Zhang, Kai ;
Xin, Shan ;
Li, Xin ;
Zhao, Yanbo ;
Wang, Yanfang .
FRONTIERS IN ONCOLOGY, 2019, 9
[17]   Genetic and structural characterization of the human mitochondrial inner membrane translocase [J].
Bauer, MF ;
Gempel, K ;
Reichert, AS ;
Rappold, GA ;
Lichtner, P ;
Gerbitz, KD ;
Neupert, W ;
Brunner, M ;
Hofmann, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (01) :69-82
[18]   The mitochondrial TIM22 preprotein translocase is highly conserved throughout the eukaryotic kingdom [J].
Bauer, MF ;
Rothbauer, U ;
Mühlenbein, N ;
Smith, RJH ;
Gerbitz, KD ;
Neupert, W ;
Brunner, M ;
Hofmann, S .
FEBS LETTERS, 1999, 464 (1-2) :41-47
[19]   Cryo-EM Structure of the TOM Core Complex from Neurospora crassa [J].
Bausewein, Thomas ;
Mills, Deryck J. ;
Langer, Julian D. ;
Nitschke, Beate ;
Nussberger, Stephan ;
Kuehlbrandt, Werner .
CELL, 2017, 170 (04) :693-+
[20]   Mitochondrial Dysfunction in Neurodegenerative Diseases [J].
Johri, Ashu ;
Beal, M. Flint .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) :619-630